News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Press Releases
Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search
here.
THE LATEST
Press Releases
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 11, 2025
August 12, 2025
·
2 min read
Press Releases
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
August 12, 2025
·
9 min read
Press Releases
Neurogene Reports Second Quarter 2025 Financial Results and Highlights Recent Updates
August 12, 2025
·
10 min read
Press Releases
Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement
August 12, 2025
·
4 min read
Press Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 11, 2025
August 12, 2025
·
1 min read
Press Releases
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025
August 12, 2025
·
20 min read
Press Releases
Fosun Pharma’s Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million
August 12, 2025
·
4 min read
Press Releases
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
August 12, 2025
·
11 min read
Press Releases
iPETcertum™ by Claritas, Developed with Cutting-Edge Technology for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scans, Receives FDA Clearance
August 12, 2025
·
3 min read
Press Releases
Tecan reports solid financial results for the first half of 2025 and confirms its outlook for full year 2025
August 12, 2025
·
15 min read
Press Releases
PharmaTher Announces FDA Approval of Ketamine (KETARx(TM))
August 11, 2025
·
6 min read
Press Releases
Antibodies Contract Manufacturing Market to Reach US$ 42.68 Bn by 2032 Driven by Therapeutic Antibody Demand and Biologic Outsourcing
August 11, 2025
·
1 min read
Press Releases
Innovative Medicine Market to Reach US$ 427.20 Billion by 2032, Growing at a 7.7% CAGR, Driven by Chronic Disease Prevalence and R&D Investment
August 11, 2025
·
1 min read
Press Releases
Blood Plasma Market to Reach US$ 79.5 Million by 2032, Driven by Rising Plasma-Derived Therapies Demand and Growing Geriatric Population
August 11, 2025
·
1 min read
Press Releases
Medicinal Herbs Market to Hit US$ 478.93 Billion by 2032, Growing at 11.21% CAGR Driven by Rising Demand for Natural Remedies and Product Innovation
August 11, 2025
·
1 min read
Press Releases
BioHarvest Sciences Reports Second Quarter 2025 Financial Results
Robust 41% Year-Over-Year Revenue Growth, Driven by Strong Core Capsule and New Product Sales
August 11, 2025
·
1 min read
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings In Cybeats Technologies Corp.
August 11, 2025
·
4 min read
Press Releases
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity’s 45th Annual Growth Conference
August 11, 2025
·
4 min read
Press Releases
Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules
August 11, 2025
·
4 min read
Press Releases
IRLAB’s CFO Viktor Siewertz Leaves the Company for a New Leading Position
August 11, 2025
·
2 min read
Press Releases
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
August 11, 2025
·
5 min read
Press Releases
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
August 11, 2025
·
5 min read
Press Releases
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
August 11, 2025
·
9 min read
Press Releases
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
August 11, 2025
·
10 min read
Press Releases
Stoke Therapeutics and Biogen Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome
August 12, 2025
·
14 min read
Press Releases
Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
August 12, 2025
·
10 min read
Press Releases
Qualia Life Sciences’ Expanding Leadership Team Announces Dan Pardi As Their New Chief Health Officer
August 12, 2025
·
2 min read
Press Releases
SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy
August 12, 2025
·
3 min read
Press Releases
TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique
August 12, 2025
·
6 min read
Press Releases
Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 12, 2025
·
10 min read
Press Releases
Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025
August 12, 2025
·
12 min read
Press Releases
ImmunityBio Announces Houston’s Michael E. DeBakey VA Medical Center Is Among the First VA Hospitals to Administer ANKTIVA® to Bladder Cancer Patients
August 12, 2025
·
8 min read
Press Releases
Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment
August 12, 2025
·
3 min read
Press Releases
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic
August 12, 2025
·
7 min read